Bacteroides fragilis subverts mucosal biology: From symbiont to colon carcinogenesis

Cynthia Louise Sears, Abby Geis, Franck Housseau

Research output: Contribution to journalArticle

Abstract

The human body comprises fewer host cells than bacterial cells, most of which are obligate anaerobes residing in the gut. The symbiont Bacteroides fragilis constitutes a relatively small proportion (up to 1%-2%) of cultured fecal bacteria, but colonizes most humans. There are 2 classes of B.fragilis distinguished by their ability to secrete a zinc-dependent metalloprotease toxin, B.fragilis toxin (BFT). Strains that do not secrete BFT are nontoxigenic B.fragilis (NTBF), and those that do are called enterotoxigenic B.fragilis (ETBF). ETBF can induce clinical pathology, including inflammatory diarrhea, although asymptomatic colonization may be common. Intestinal inflammation is mediated by BFT, as yet the only known virulence factor of ETBF. Recent experimental evidence demonstrating that ETBF-driven colitis promotes colon tumorigenesis has generated interest in the potential contribution of ETBF to human colon carcinogenesis. Critical questions about the epidemiology of chronic, subclinical human colonization with ETBF and its impact on the biology of the colon need to be addressed.

Original languageEnglish (US)
Pages (from-to)4166-4172
Number of pages7
JournalJournal of Clinical Investigation
Volume124
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Bacteroides fragilis
Colon
Carcinogenesis
Clinical Pathology
Metalloproteases
Virulence Factors
Colitis
Human Body
Zinc
Diarrhea
Epidemiology
Inflammation
Bacteria

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bacteroides fragilis subverts mucosal biology : From symbiont to colon carcinogenesis. / Sears, Cynthia Louise; Geis, Abby; Housseau, Franck.

In: Journal of Clinical Investigation, Vol. 124, No. 10, 01.10.2014, p. 4166-4172.

Research output: Contribution to journalArticle

@article{3af94f7c24864e399e5e6a060a4c0c9c,
title = "Bacteroides fragilis subverts mucosal biology: From symbiont to colon carcinogenesis",
abstract = "The human body comprises fewer host cells than bacterial cells, most of which are obligate anaerobes residing in the gut. The symbiont Bacteroides fragilis constitutes a relatively small proportion (up to 1{\%}-2{\%}) of cultured fecal bacteria, but colonizes most humans. There are 2 classes of B.fragilis distinguished by their ability to secrete a zinc-dependent metalloprotease toxin, B.fragilis toxin (BFT). Strains that do not secrete BFT are nontoxigenic B.fragilis (NTBF), and those that do are called enterotoxigenic B.fragilis (ETBF). ETBF can induce clinical pathology, including inflammatory diarrhea, although asymptomatic colonization may be common. Intestinal inflammation is mediated by BFT, as yet the only known virulence factor of ETBF. Recent experimental evidence demonstrating that ETBF-driven colitis promotes colon tumorigenesis has generated interest in the potential contribution of ETBF to human colon carcinogenesis. Critical questions about the epidemiology of chronic, subclinical human colonization with ETBF and its impact on the biology of the colon need to be addressed.",
author = "Sears, {Cynthia Louise} and Abby Geis and Franck Housseau",
year = "2014",
month = "10",
day = "1",
doi = "10.1172/JCI72334",
language = "English (US)",
volume = "124",
pages = "4166--4172",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - Bacteroides fragilis subverts mucosal biology

T2 - From symbiont to colon carcinogenesis

AU - Sears, Cynthia Louise

AU - Geis, Abby

AU - Housseau, Franck

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The human body comprises fewer host cells than bacterial cells, most of which are obligate anaerobes residing in the gut. The symbiont Bacteroides fragilis constitutes a relatively small proportion (up to 1%-2%) of cultured fecal bacteria, but colonizes most humans. There are 2 classes of B.fragilis distinguished by their ability to secrete a zinc-dependent metalloprotease toxin, B.fragilis toxin (BFT). Strains that do not secrete BFT are nontoxigenic B.fragilis (NTBF), and those that do are called enterotoxigenic B.fragilis (ETBF). ETBF can induce clinical pathology, including inflammatory diarrhea, although asymptomatic colonization may be common. Intestinal inflammation is mediated by BFT, as yet the only known virulence factor of ETBF. Recent experimental evidence demonstrating that ETBF-driven colitis promotes colon tumorigenesis has generated interest in the potential contribution of ETBF to human colon carcinogenesis. Critical questions about the epidemiology of chronic, subclinical human colonization with ETBF and its impact on the biology of the colon need to be addressed.

AB - The human body comprises fewer host cells than bacterial cells, most of which are obligate anaerobes residing in the gut. The symbiont Bacteroides fragilis constitutes a relatively small proportion (up to 1%-2%) of cultured fecal bacteria, but colonizes most humans. There are 2 classes of B.fragilis distinguished by their ability to secrete a zinc-dependent metalloprotease toxin, B.fragilis toxin (BFT). Strains that do not secrete BFT are nontoxigenic B.fragilis (NTBF), and those that do are called enterotoxigenic B.fragilis (ETBF). ETBF can induce clinical pathology, including inflammatory diarrhea, although asymptomatic colonization may be common. Intestinal inflammation is mediated by BFT, as yet the only known virulence factor of ETBF. Recent experimental evidence demonstrating that ETBF-driven colitis promotes colon tumorigenesis has generated interest in the potential contribution of ETBF to human colon carcinogenesis. Critical questions about the epidemiology of chronic, subclinical human colonization with ETBF and its impact on the biology of the colon need to be addressed.

UR - http://www.scopus.com/inward/record.url?scp=84907487930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907487930&partnerID=8YFLogxK

U2 - 10.1172/JCI72334

DO - 10.1172/JCI72334

M3 - Article

C2 - 25105360

AN - SCOPUS:84907487930

VL - 124

SP - 4166

EP - 4172

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -